About: Angelini

An Entity of Type: Private company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Angelini is a medium-sized private international group. Founded in Italy in the early twentieth century, the Angelini group has offices in 25 countries. Led by President Francesco Angelini, the industrial group employs approximately 3000 people. The antidepressant medication Trazodone was developed in the 1960s by scientists at Angelini. In a 2018 evaluation of firms' reputation issued by Reputation Institute, Angelini ranked 66th in general and second among life sciences companies. In January 2021, the Swiss biotech company Arvelle Therapeutics was acquired for $960 million.

Property Value
dbo:abstract
  • Angelini is a medium-sized private international group. Founded in Italy in the early twentieth century, the Angelini group has offices in 25 countries. Led by President Francesco Angelini, the industrial group employs approximately 3000 people. The antidepressant medication Trazodone was developed in the 1960s by scientists at Angelini. In a 2018 evaluation of firms' reputation issued by Reputation Institute, Angelini ranked 66th in general and second among life sciences companies. In 2020, Angelini took over ownership of Thermacare after Pfizer spun off the transdermal analgesic patch after its merger with GlaxoSmithKline's consumer healthcare division. In January 2021, the Swiss biotech company Arvelle Therapeutics was acquired for $960 million. (en)
  • Die Angelini-Gruppe ist ein international tätiges italienisches Pharmaunternehmen mit Niederlassungen in 20 Ländern. (de)
  • Angelini est une entreprise pharmaceutique italienne fondée en 1919. (fr)
  • Il Gruppo Angelini, noto anche come Angelini, è una multinazionale italiana che opera nell'area della salute e del benessere nei settori farmaceutico e dei prodotti di largo consumo, nella meccanica, nel vitivinicolo e nei profumi. Ha sede a Roma in Viale Amelia, 70. (it)
dbo:foundingYear
  • 1919-01-01 (xsd:gYear)
dbo:industry
dbo:revenue
  • 1.4E9
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 14909889 (xsd:integer)
dbo:wikiPageLength
  • 3217 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1100306314 (xsd:integer)
dbo:wikiPageWikiLink
dbp:areaServed
  • Worldwide (en)
dbp:foundation
  • 1919 (xsd:integer)
dbp:homepage
dbp:industry
dbp:keyPeople
  • Francesco Angelini (en)
dbp:locationCity
  • Rome, Italy (en)
dbp:logo
  • Angelini Logo.jpg (en)
dbp:logoSize
  • 250 (xsd:integer)
dbp:name
  • Angelini (en)
dbp:nativeNameLang
  • de (en)
dbp:numEmployees
  • Approx. 3000 (en)
dbp:revenue
  • Approx. 1.4 Billion Euro (en)
dbp:type
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Die Angelini-Gruppe ist ein international tätiges italienisches Pharmaunternehmen mit Niederlassungen in 20 Ländern. (de)
  • Angelini est une entreprise pharmaceutique italienne fondée en 1919. (fr)
  • Il Gruppo Angelini, noto anche come Angelini, è una multinazionale italiana che opera nell'area della salute e del benessere nei settori farmaceutico e dei prodotti di largo consumo, nella meccanica, nel vitivinicolo e nei profumi. Ha sede a Roma in Viale Amelia, 70. (it)
  • Angelini is a medium-sized private international group. Founded in Italy in the early twentieth century, the Angelini group has offices in 25 countries. Led by President Francesco Angelini, the industrial group employs approximately 3000 people. The antidepressant medication Trazodone was developed in the 1960s by scientists at Angelini. In a 2018 evaluation of firms' reputation issued by Reputation Institute, Angelini ranked 66th in general and second among life sciences companies. In January 2021, the Swiss biotech company Arvelle Therapeutics was acquired for $960 million. (en)
rdfs:label
  • Angelini (en)
  • Angelini-Gruppe (de)
  • Angelini (entreprise) (fr)
  • Gruppo Angelini (it)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Angelini (en)
is dbo:wikiPageWikiLink of
is dbp:currentowner of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License